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PlasticityThe effects of peripheral nerve injury on somatosensory processing and pain are highly dependent upon the age
at which the damage occurs. Adult nerve injury rapidly triggers neuropathic pain, but this is not so if the same
nerve injury is performed in animals below postnatal day (P) 28, consistent with observations in paediatric
patients. However, longitudinal studies show that pain hypersensitivity emerges later in life, when the animal
reaches adolescence, an observation that could be of clinical importance. Here we discuss the evidence that the
central consequences of nerve damage are critically determined by the status of neuroimmune regulation at
different ages. In the ﬁrst postnatal weeks, when spinal somatosensory circuits are undergoing synaptic
reorganisation, the ‘default’ neuroimmune response is skewed in an anti-inﬂammatory direction, suppressing
the excitation of dorsal horn neurons and preventing the onset of neuropathic pain. As animals grow up and
the central nervous system matures, the neuroimmune proﬁle shifts in a pro-inﬂammatory direction,
unmasking a ‘latent’ pain response to an earlier nerve injury. The data predicts that nerve injury in infancy
and childhood could go unnoticed at the time, but emerge as clinically ‘unexplained’ or ‘functional’ pain in
adolescence.
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1.1. The ﬁrst phase — No neuropathic pain
Peripheral nerve damage in early life does not simply remove a
source of sensory input from the somatosensory system, it triggers
great change in neural circuitry and leads to long term alterations spinal
somatosensory function. However, the nature of these changes is
dependent upon when exactly, in terms of postnatal age, this nerve
damage occurs.
A major consequence of nerve damage, in adult man and laboratory
animals, is the onset of neuropathic pain, characterised by allodynia and
pain hypersensitivity from the partially denervated regions (Gilron
et al., 2015). Thus, spared nerve injury (SNI), a classic partial denerva-
tion model (Decosterd and Woolf, 2000), produces robust mechanical
allodynia, measured as a fall in hindpaw cutaneous sensory threshold
to 16% of controls, within one postoperative day and lasting at least
28 days (Howard et al., 2005).
Strikingly, neuropathic pain does not arise if exactly the same nerve
injury is performed in young animals. Rat pups aged 3, 10 and 21 days at
the time of surgery do not display equivalent allodynia at any time up to
28 days later (Howard et al., 2005). Only at postnatal day (P) 33 does
SNI lead to a signiﬁcant and persistent allodynia with the threshold
falling to 55% of control values. A comparable lack of neuropathic pain
behaviour is observed in other models of juvenile nerve injury: chronic
constriction injury (CCI) causes a clear allodynia in adult rats but no
change in hindpaw sensitivity when performed at 10 days of age
(Howard et al., 2005) and the more proximal injury, spinal nerve
ligation, causes only transient allodynia when performed at P14 (Ririe
and Eisenach, 2006). This data has been conﬁrmed in other studies
(Costigan et al., 2009; Moss et al., 2007; Vega-Avelaira et al., 2009)
and recently extended beyond mechanical allodynia to cool and cold
allodynia, and altered weight bearing, all of which develop within a
few days of adult SNI but are absent following SNI performed at P10
(McKelvey et al., 2015).
This ﬁnding is consistent with clinical experience. Neuropathic pain
following nerve injury is rare in infants, and only very few reports exist
before 5–6 years of age (Anand and Birch, 2002; Howard et al., 2014;
Walco et al., 2010) and the incidence of neuropathic pain increases
with age at which nerve damage occurs (Atherton et al., 2008). Thirteen
years is the median age of onset for paediatric neuropathic pain syn-
dromes, such as phantom pain, complex regional pain syndrome, and
peripheral neuropathy pain (Walco et al., 2010) but the reasons for
this are not known. Although many of the underlying disease states
involving neuropathic pain are less frequent in children, it is also evi-
dent that nerve damage is more likely to trigger pain in late childhood
and adolescence than at younger ages.
1.2. The delayed phase — Late onset neuropathic pain
Infants of all mammalian species tested are capable of displaying ro-
bust nociceptive responses to noxious mechanical, thermal and
chemical stimulation and develop persistent allodynia and hyperalgesia
in response to inﬂammation of the skin, joints and viscera. So the ques-
tion remains as to why there is a speciﬁc absence of neuropathic pain
following nerve injury at younger ages. Clues to this may provide a
new insight into this most unpleasant of pain conditions.
Recent longitudinal studies have discovered a novel consequence
of juvenile nerve injury. Mechanical hypersensitivity, characteristic of
neuropathic pain, does occur but only later in life. While spared nerve
injury (SNI) at (P10) has no effect on sensory thresholds in the ﬁrst
2–3 weeks post-P10 surgery, after that time period, beginning at
21days post-surgery (P31), the SNI group develop signiﬁcant hypersen-
sitivity (Vega-Avelaira et al., 2012). This delayed adolescent onset hy-
persensitivity is also observed using cold stimulation and weight
bearing tests but not noxious heat stimulation (McKelvey et al., 2015).Interestingly, clinical investigation of phantom limb pain in adoles-
cence shows that children with the earliest amputations do develop
phantom pain but only after a considerable delay, of a mean of 7 years
(Melzack et al., 1997). Furthermore several complex pain syndromes
(e.g. CRPS) that emerge in older children are associated with little or
nomeasurable disease activity or inﬂammation at the time of presenta-
tion and are clinically deﬁned as ‘functional’ or ‘medically unexplained’
(Bromberg et al., 2014). This led us to hypothesise that the changes in
pain processing over infancy, childhood and adolescence may be of
special signiﬁcance in understanding the maturation of neuropathic
pain.
In this review we examine the immediate and longer term changes
in dorsal horn nociceptive circuits that follow experimental nerve injury
in infant, juvenile and adolescent rats. We present evidence that the
clue to the late development of neuropathic pain lies in the maturation
of neuroimmune regulation of pain pathways in the spinal cord dorsal
horn.
2. Cellular effects of nerve injury in early life:
The ﬁrst phase (no pain)
2.1. Cell death and compensatory sprouting
In adults, there is some evidence for cell death in the dorsal root
ganglia and dorsal horn following nerve injury but this is limited
and only observed after a considerable time post-injury (Scholz
et al., 2005; Tandrup et al., 2000). The situation is quite different fol-
lowing nerve injury in the immediate postnatal period. Sensory
neurons in the rat dorsal root ganglion (DRG) are still undergoing
axonal growth and naturally occurring cell death in the ﬁrst postna-
tal week and are highly dependent upon their peripheral target skin
and muscle for survival (Chong et al., 1992; Coggeshall et al., 1994).
As a result, nerve damage in the immediate postnatal period causes
substantial and rapid cell death (of up to 75% neurons) in the dorsal
root ganglion (Himes and Tessler, 1989; Whiteside et al., 1998; Yip
et al., 1984).
The loss of sensory neurons following early nerve damage triggers
axonal sprouting within the damaged nerve itself and collateral
sprouting of adjacent intact afferent terminals into the denervated
region of the dorsal horn. For example, following sciatic nerve section
at postnatal day (P) 1, the adjacent saphenous nerve dorsal horn termi-
nal ﬁeld doubles in size, expanding into areas normally occupied by
sciatic nerve terminals, with single afferents growing up to 2000 μm
into the deafferented sciatic terminal ﬁeld (Fitzgerald, 1985; Fitzgerald
et al., 1990; Fitzgerald and Vrbová, 1985). Both A ﬁbres and substance
P- and CGRP-expressing C ﬁbres are involved in this sprouting
(Reynolds and Fitzgerald, 1992; Shortland and Fitzgerald, 1994). The
A ﬁbre terminals of surviving axotomized primary afferent neurons
also sprout dorsally into lamina II and join the invading intact A and C
ﬁbres contributing to the overlap in central representation of nerve
territories (Shortland and Fitzgerald, 1994).
Importantly, the new sprouted terminals form functional connec-
tions with dorsal horn neurons, such that cells that normally only
respond to inputs from the damaged nerves now respond to intact
inputs from adjacent body areas. For example, after neonatal sciatic
nerve section, dorsal horn neurons with receptive ﬁelds in the saphe-
nous skin region can be found throughout L3, L4 and L5 segments,
while they are normally restricted to L3 and rostral L4 (Shortland and
Fitzgerald, 1991) and stimulation of nearby intact nerves evoke greater
fos activation in denervated areas of the dorsal horn (Shortland and
Molander, 2000). Nevertheless, loss of primary afferent input apparently
withdraws trans-synaptic trophic support from the dorsal horn and
projection neurons have substantially fewer primary dendrites and
secondary branches compared to controls following neonatal nerve
damage (Fitzgerald and Shortland, 1988) accompanied by a small loss
of interneurons (Lowrie and Lawson, 2000).
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performed in the ﬁrst days after birth. The need for neurotrophic
support from target tissues passes and there is no DRG cell death or
compensatory central afferent terminal sprouting, and little somato-
topic map reorganisation or transsynaptic trophic changes after the
ﬁrst week of life (Fitzgerald, 1985; Fitzgerald and Shortland, 1988;
Shortland and Fitzgerald, 1994). Thus nerve damage in the second post-
natal week, at P10 and P21 does not cause any DRG cell loss (Himes and
Tessler, 1989; Whiteside et al., 1998) and central afferent sprouting
declines sharply with age at the time of nerve damage, being very
weak if damage is on day 5, and non-existent if sectioning takes place
on day 10 (Fitzgerald, 1985).
These changes cannot therefore explain the lack of neuropathic pain
which follows nerve injury performed up to 28 days after birth (Howard
et al., 2005; McKelvey et al., 2015).
2.2. Glial responses: Weak microglial activation and release of
anti-inﬂammatory cytokines
The absence of neuropathic pain following early life nerve injury has
been ascribed to the low level glial response in the dorsal horn of the
spinal cord. In adults the role of the immune system in the development
and maintenance of neuropathic pain is well documented and is domi-
nated by a rapid onset pro-inﬂammatory response that leads to the
sensitization of neurons in the dorsal horn and pain-like hypersensitiv-
ity (Coull et al., 2005; Gao and Ji, 2010; Taves et al., 2013). In contrast
to the effects in adults, spared nerve injury at P10 causes little or no in-
crease in the expression of eithermicroglia (MHC-II DMα, MHC-II DMβ,
integrin-αM, CD68, IBA-1) or astrocyte (GFAP) markers in the dorsal
horn spinal cord (Costigan et al., 2009; Moss et al., 2007; Vega-Avelaira
et al., 2007, 2009) and no increase the expression of pro-inﬂammatory
mediators, including TNF, BDNF or IFN-γ in the dorsal horn 7 days
after surgery (Costigan et al., 2009; McKelvey et al., 2015). Importantly,
intraspinal injections of lipopolysaccharide (LPS) or N-methyl-D-
aspartate (NMDA) can activate microglia at this age showing that the
innate immune responsiveness of the microglia themselves is not the
problem (Moss et al., 2007). This blunted response is also observed
in infant rats following other insults such as peripheral nerve C-ﬁbre
stimulation, where immune cells mount a weak inﬂammatory cytokine
production associated with fewer protective immune cells compared to
adults (Hathway et al., 2009).
The weak microglial response to juvenile nerve injury is accompa-
nied by a distinct dorsal horn cytokine response that differs consider-
ably from that following adult nerve injury. While there is a limited
pro-inﬂammatory response, SNI in infants induces a striking increase
in the expression of anti-inﬂammatory mediators, characterised by an
increase in the expression of the transcription factor GATA3, and the
cytokines, IL-10 and IL-4 (McKelvey et al., 2015). GATA3 is a regulator
of T-cell development and promotes the differentiation of CD4 T-cells
into a Th2 cell lineage and the secretion of anti-inﬂammatory cytokines
including IL-4, IL-10, and IL-13 while inhibiting Th1 cell differentiation
and IFN-γ production (Ferber et al., 1999; Ouyang et al., 1998). IL-4
signalling induces T-cell proliferation and differentiation into a Th2
phenotype and suppresses macrophage and microglia M1 phenotypes
and pro-inﬂammatory mediator expression (Stein et al., 1992). IL-10
also acts to inhibit pro-inﬂammatorymediator release as well as reduc-
ing the recruitment of immune related glia cells in the spinal cord
(Gordon, 2003; Milligan and Watkins, 2009; Ponomarev et al., 2005).
The upregulated IL-10, IL-4 and GATA3 are commonly associated with
T cells and while resident CD2+ T-cell numbers are not increased
following infant nerve injury (Costigan et al., 2009), it is possible that
their activity is altered. Furthermore microglia or neurons themselves
may be a source of anti-inﬂammatory cytokines (Milligan and Watkins,
2009; Ponomarev et al., 2005). LPS application to microglia derived
from infant spinal cords signiﬁcantly increases IL-10 release and IL-10
mRNA expression in vitro (Werry et al., 2011).The dominant anti-inﬂammatory response following nerve injury
does not mean that immature pain circuits are incapable of responding
to pro-inﬂammatory mediators or that they are not released in young
spinal cord. Nerve injury sensitizes neonatal lamina I neurons to TNF
in vitro (Li andBaccei, 2011) and intrathecal application of TNF and lipo-
polysaccharide (LPS) activated microglia are both able to overcome the
anti-inﬂammatory activity following nerve injury in infant mice and
induce mechanical hypersensitivity (McKelvey et al., 2015). Thus infant
rodents are able to respond to stressors such as TNF or LPS-activated
microglia (which can release TNF to sensitize dorsal horn neurons and
enhance pain states (Berta et al., 2014)) and infant spinal microglia
are clearly activated by peripheral inﬂammatory stimulation (Vega-
Avelaira et al., 2013) but followingnerve injury,microglia are apparently
stopped from producing TNF and BDNF by a nerve injury-induced
anti-inﬂammatory response.
The infant anti-inﬂammatory response does not require actual nerve
damage; it can also be evoked by brief stimulation of intact afferent
C ﬁbre nociceptors in infants (McKelvey et al., 2015). The same C ﬁbre
stimulation in adults induces painhypersensitivity andmicroglia activa-
tion in the spinal cord, that are attenuated by pre-treatment with
minocycline (Hathway et al., 2009), an inhibitor of pro-inﬂammatory
polarisedmicroglia (Kobayashi et al., 2013), thus transiently mimicking
changes in the dorsal horn that underpin chronic pain states (Taves
et al., 2013). The fact that C-ﬁbre stimulation in infants stimulates ex-
pression of anti-inﬂammatory IL-10 and IL-4 (McKelvey et al., 2015),
suggests that their release is directly activated by neurotransmitter
release from C ﬁbre terminals in the dorsal horn and that the response
following infant nerve injury could be a direct result of activity in
damaged C ﬁbre afferent terminals.
3. Cellular effects of nerve injury in early life:
The delayed phase (late onset pain)
3.1. Glial responses: Increased microglial activation and release of
pro-inﬂammatory cytokines
Longitudinal studies have shown that following nerve injury at post-
natal day (P) 10 there is a delayed onset of pain hypersensitivity
(McKelvey et al., 2015; Vega-Avelaira et al., 2012) and that this is
accompanied by increased microglial activation and NMDA dependent
central sensitization of spinal nociceptive circuits, but no signiﬁcant
change in dorsal horn p38 or JNK expression. Pre-emptive minocycline
administered daily (from before P10 surgery until P21), does not pre-
vent the effect, perhaps because minocycline is a p38 inhibitor, and
p38 does not to play a part in this process (Garrido-Mesa et al., 2013;
Vega-Avelaira et al., 2012). On the other hand ketamine produces a
dose-dependent reversal of hypersensitivity to mechanical stimulation
(Vega-Avelaira et al., 2012), suggesting that the onset of hypersensitiv-
ity is due to a maintained NMDA mediated central sensitization. The
delayed mechanical hypersensitivity coincides with an increase in the
expression of immune cell markers (microglia and T-cells), and expres-
sion pro-inﬂammatorymediators including TNF and BDNF that can alter
synaptic transmission in the dorsal horn and are associated with pain
sensitization (Coull et al., 2005; Taves et al., 2013). In addition, the
anti-inﬂammatory mediators (IL-10 and IL-4) that were upregulated
in the early post-nerve injury phase and can act in a regulatory capacity
to control inﬂammation, are now reduced to sham control levels
(McKelvey et al., 2015).
Thus, as the nerve injured infants grow up, the anti-inﬂammatory
response changes to a proinﬂammatory response; levels of the anti-
inﬂammatory mediators IL-4 and IL-10 return to control levels and
GATA3 falls transiently below control levels, whereas expression of pro-
inﬂammatory markers, IBA1, BDNF, and TNFα increase. Notably, the
switch to a proinﬂammatory response coincides with a delayed onset
of mechanical hypersensitivity and a signiﬁcant increase in sponta-
neous, tactile and acetone-evoked activity in dorsal horn neurons,
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Because the levels of GFAP do not increase at this time, astrocyte activa-
tion is unlikely to drive delayed-onset hypersensitivity. The timing is
entirely consistentwith the reported postnatal change in toll-like recep-
tor (TLR) inducible cytokine and chemokine release from microglia,
which is at its lowest at postnatal day 21 but rises considerably towards
adolescence (Scheffel et al., 2012). Thus, despite the fact that the nerve
injury was performed in infancy, pain behaviour emerges at adoles-
cence, at least in part as a result of a change in neuroimmune activity.
3.2. Delayed neuropathic pain can be ‘unmasked’ at an earlier age by
suppressing anti-inﬂammatory cytokine function
Wehave recently shown that the upregulated anti-inﬂammatory cy-
tokines during the early phase following infant nerve injury actively
suppresses neuropathic pain in the weeks following surgery. Blockade
of IL-10 activity with intrathecal functional blocking antibody for three
consecutive days (7–9 days post-surgery at P10) causes a signiﬁcant hy-
persensitivity to mechanical stimulation in nerve injured but not sham
operated mice. Thresholds recovered 24 h after the last injection. Intra-
thecal injection of the control antibody (IgG) into infant SNI mice did
not induce signiﬁcant changes inmechanical thresholds. In adults, intra-
thecal administration of anti-IL-10 after SNI has no signiﬁcant effect on
mechanical thresholds at any time (McKelvey et al., 2015).
Thus the release of IL-10 followingnerve injury is functionally essen-
tial for the absence of mechanical hypersensitivity. Neuropathic pain is
therefore not really absent in the early phase, but actively suppressed
and can be unmasked if the anti-inﬂammatory response is blocked.
Exogenous IL-10 and IL-4 are anti-nociceptive in adult neuropathic
models, suppressing proinﬂammatory cytokines, microglia responses
and pain behaviour (Milligan et al., 2005; Milligan and Watkins, 2009)
and our results show that in infants this antinociception naturally
dominates following nerve injury (McKelvey et al., 2015).
4. What triggers delayed onset neuropathic pain?
4.1. A natural transient developmental role for anti-inﬂammatory activity
in the CNS
It appears then, that neuropathic pain can emerge later in life,
following earlier nerve injury due to a natural developmental change
in the neuroimmune system (Fig. 1). In the ﬁrst weeks of life, glial cell
activity within the dorsal horn is tailored to the natural requirements
of a growing neural circuit. Microglia are the principal resident innate
immune cells in the central nervous system (CNS) and are essential
during the early development for synaptic pruning, developmental
neuronal apoptosis and remodelling (Paolicelli et al., 2011; Schafer
et al., 2012). Microglia undergo striking transformations in both mor-
phology and activity during development (Harry, 2013; Harry and
Kraft, 2012) displaying an activated morphology and high phagocytic
activity during the postnatal period in contrast to the lowmitotic activ-
ity and highly motile processes of adult microglia, that constantly
survey their microenvironment. Microglia also express higher levels of
iNOS, TNFα and arginase-I mRNA in early postnatal development com-
pared to the adult CNS (Crain et al., 2013), suggesting that their activi-
ties in the developing CNS may be distinct from those in the adult.
Microglial cell numbers increase within the ﬁrst 2 postnatal weeks
and decline in the third week; microglial density in the postnatal CNS
is two times higher than in the adult. This supports the notion that
during the early postnatal period, the primary function of microglia
may be to participate in “building” the CNS, whereas in adulthood,
microglia switch to a maintenance/surveillance mode (Nikodemova
et al., 2015).
The recently discovered novel anti-inﬂammatory response to nerve
injury in young rats and mice (McKelvey et al., 2015) is consistent
with the ‘default’ immune response in neonates which is skewedin an anti-inﬂammatory direction (Adkins, 2000; Elahi et al., 2013;
PrabhuDas et al., 2011). It is increasingly recognised that the immune
proﬁle in both peripheral (T-cells) and central residing immune
cells (microglia) undergo a developmental shift with age from an
anti-inﬂammatory skewed response (such as high IL-10) to pro-
inﬂammatory in both rodents and humans (Elahi et al., 2013;
PrabhuDas et al., 2011; Shigemoto-Mogami et al., 2014). For example
cytokine analysis of LPS-activated microglia between P0 to P49 mice
reveal a gradual developmental shift to a defence-orientatedM1pheno-
type, with an increasing induction of TNF-α, IL-1β, IL-6 and a decline in
arginase with age (Scheffel et al., 2012). In addition, following both LPS
and non-TLR mediated challenges discrete subsets of microglia secrete
TNFαwith increasing age indicating a shift towards microglia response
heterogeneity (Scheffel et al., 2012).
4.2. A shift in neuroimmune regulation as nociceptive circuits mature
The function of a predominant anti-inﬂammatory response ob-
served during this postnatal period in response to nerve injury and
other insults may have evolved to prevent excessive inﬂammation fol-
lowing the transition from a sterile in utero setting to colonization
with commensal microbes (Maynard et al., 2012). In addition, studies
in the healthy brain indicate a dual role for microglia during postnatal
development associated with the substantial changes that occur in the
connectivity of the CNS over this period. This includes their ability to re-
move cellular debris and dead cells via phagocytosis activity and sec-
ondly, to establish contacts with synapses and regulate the size of
dendritic spines during critical periods (Arnoux et al., 2014; Schafer
et al., 2012). For example, microglia within the juvenile visual cortex
canmodify their associationwith dendritic spines in response to chang-
es in visual sensory experience and actively engulf synaptic structures
and exert a major role in controlling the number of synapses through
synaptic pruning (Tremblay et al., 2010). This is conﬁrmed by the ﬁnd-
ing that disruption inmicroglial function, such as depletion of microglia
CX3CL1 receptor or administration of a microglial inhibitor, results in
delayed synaptic pruning and maturation of hippocampal synaptic cir-
cuits (Paolicelli et al., 2011; Schafer et al., 2012). As substantial rear-
rangement and reﬁnement of synaptic connections occur in the ﬁrst
weeks in the dorsal horn (Fitzgerald, 2005), it is possible that dorsal
horn microglia are enabling the reﬁnement and rearrangement of syn-
aptic connections and pruning of axonal projections, temporarily in-
creasing the production of damage associated molecular patterns
(DAMP). In other words, the anti-inﬂammatory response to nerve dam-
age in infants may be the indirect consequence of the requirements for
normal postnatal development in the dorsal horn (Beggs et al., 2002;
Bremner and Fitzgerald, 2008; Koch et al., 2012). As a result, a peripher-
al nerve injury at P10, activates signalling pathways associated with a
default anti-inﬂammatory immune response in the dorsal horn spinal
cord and the absence of pain like behaviour, enabling normal postnatal
development in the dorsal horn to occur through phagocytic activity,
without the initiation of an extensive and damaging inﬂammatory re-
sponse and associated hypersensitivity.
4.3. An explanation for ‘unexplained’ pain in adolescence?
In this review we have argued that, depending on the developmen-
tal status of the animal, nerve injury will trigger different immune
responses in the dorsal horn spinal cord (Fig. 1). In very young animals,
equivalent to preterm infants, the response to nerve injury is cell death
in the DRG and compensatory sprouting and reorganisation of the
somatosensory and pain system. Microglial are permissive and their
main duty is phagocytosis at this time. Later, in animals aged P10–P21,
equivalent to infancy and childhood, this neural plasticity is lost but
the nociceptive circuits are still undergoing important maturation
facilitated by permissive immune system. At this age, nerve injury
evokes an anti-inﬂammatory immune response, characterised by the
Fig. 1. The dorsal horn response to peripheral nerve injury depends upon age. Amodel is proposed above of the cellular activity in the dorsal horn following nerve injury at different time
points and postnatal stages Top: Neonatal (day 1–7) nerve injury results in primary afferent sprouting, and there is no pain behaviour. It is proposed that microglia are phagocytic (blue
cells) and resident T helper cells (pink circular cells) are predominantly type Th2, that is anti-inﬂammatory. This cellular environment promotes and supports structural plasticity and
postnatal neuronal circuit development (dark red neurons). Centre: Juvenile (day 10) nerve injury initially triggers an anti-inﬂammatory response in the dorsal hornwith anti-inﬂamma-
tory T helper cell activity (Th2) andmicroglial activity (M2) associated with release of cytokines such as IL4 and IL10. There is no pain behaviour. Bottom: Juvenile (day 10) nerve
injury causes a later, delayed onset pro-inﬂammatory response in the dorsal horn. This arises from a switch of microglial and T cell activity from M2 and Th2 to M1 and Th1,
associated with the release of pro-inﬂammatory cytokines such as IL1, TNF and the neurotrophin, BDNF. These, in turn, excite dorsal horn neurons and as a result trigger pain behaviour.
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released at this age by peripheral nerve C-ﬁbre stimulation. The anti-
inﬂammatory cascade in the dorsal horn suppresses neuronal
sensitization, and so pain is naturally suppressed in the early period
following infant nerve injury. However, as the animal grows up towardsadolescence, a gradual developmental change occurs in the balance
of neuroimmune regulation towards a pro-inﬂammatory response, per-
haps to protect against foreign invasion, which dominates and allows
the expression of neuronal sensitization and the appearance of pain
like behaviour. Important other contributors, yet to be tested, could be
301M. Fitzgerald, R. McKelvey / Experimental Neurology 275 (2016) 296–302stress, that can increase the likelihood of maladaptive immune re-
sponses (Graham et al., 2006), and sex differences in glial function con-
tributing to distinct windows of adolescent vulnerability in females
(Schwarz and Bilbo, 2012). If the data translates to man, it suggests
that nerve injury in early life may go unnoticed at the time of injury,
but could emerge in later life as an ‘unexplained’ or ‘functional’ pain.
Thus adolescent onset complex pain behaviours may be attributable to
unreported injury in early life.
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